TY  - GEN
AU  - Zarzuelo-Romero, Maria Jose
AU  - Perez-Ramirez, Cristina
AU  - Cura, Yasmin
AU  - Carrasco-Campos, Maria Isabel
AU  - Marangoni-Iglecias, Luciana Maria
AU  - Ramirez-Tortosa, Maria Carmen
AU  - Jimenez-Morales, Alberto
PY  - 2021
DO  - 10.3390/jpm11101032
UR  - https://hdl.handle.net/10668/26323
T2  - Journal of personalized medicine
AB  - Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of autoimmune origin, in which inflammation and demyelination lead to neurodegeneration and progressive disability. Treatment is aimed at slowing down the course of the disease...
LA  - en
PB  - Mdpi
KW  - multiple sclerosis
KW  - glatiramer acetate
KW  - myelin basic protein
KW  - response
KW  - treatment
KW  - polymorphisms
KW  - pharmacogenetics
KW  - medicine personalized
KW  - Genome-wide association
KW  - Myelin basic-protein
KW  - Regulatory t-cells
KW  - Treatment response
KW  - Human-chromosome
KW  - Disease-activity
KW  - Interferon-beta
KW  - Mutations cause
KW  - Double-blind
KW  - Expression
TI  - Influence of Genetic Polymorphisms on Clinical Outcomes of Glatiramer Acetate in Multiple Sclerosis Patients
TY  - review
VL  - 11
ER  -